title: Binding of the doxorubicin-lactosaminated human albumin conjugate to HCC cells is mediated by the drug moieties.
authors.forename: M
authors.initials: M
authors.lastname: Baglioni
authors.forename: L
authors.initials: L
authors.lastname: Fiume
authors.forename: L
authors.initials: L
authors.lastname: Bolondi
authors.forename: C
authors.initials: C
authors.lastname: Farina
authors.forename: F
authors.initials: F
authors.lastname: Kratz
authors.forename: G
authors.initials: G
authors.lastname: Di Stefano
mesh_terms: D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000493:pharmacokinetics*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D045744:Cell Line, Tumor; D004317:Doxorubicin / Q000493:pharmacokinetics*; D004337:Drug Carriers / Q000493:pharmacokinetics; D015195:Drug Design; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D051381:Rats; D012709:Serum Albumin / Q000493:pharmacokinetics
chemical_list: D000903:Antibiotics, Antineoplastic; D004337:Drug Carriers; D012709:Serum Albumin; C046912:lactosaminated serum albumin; D004317:Doxorubicin